Study of AZD4512 monotherapy or in combination with anticancer agents in participants with acute lymphoblastic leukemia

Trial Identifier: D9891C00001
Sponsor: AstraZeneca
Collaborator:
Fortrea INC.
Start Date: October 2025
Primary Completion Date: April 2028
Study Completion Date: July 2028

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
AU Melbourne, AU, 3000
CA, ON Toronto, ON, CA, M5G 1X6
ES Barcelona, ES, 08035
ES Salamanca, ES, 37007
ES Santander, ES, 39008
ES Valencia, ES, 46026
GB London, GB, NW1 2PG
GB Manchester, GB, M20 4BX
JP Bunkyo-ku, JP, 113-8677
JP Chuo-ku, JP, 104-0045
KR Seoul, KR, 06591
KR Seoul, KR, 03080
KR Seoul, KR, 3722
KR Seoul, KR, 06351
TW Taichung, TW, 40705
TW Taipei City, TW, 106
US, CA Duarte, CA, US, 91010
US, FL Jacksonville, FL, US, 32224
US, IA Iowa City, IA, US, 52242
US, IL Chicago, IL, US, 60611
US, TN Nashville, TN, US, 37203
US, TX Houston, TX, US, 77030